Emerging Viral Vectors And Plasmid DNA Market Trend 2025-2034: Unaffordable Gene Therapy Costs Challenge Viral Vectors And Plasmid DNA Market

How Is the Viral Vectors And Plasmid DNA Market Projected to Grow, and What Is Its Market Size?
The market for viral vectors and plasmid DNA has expanded rapidly in the recent past. It is expected to increase from $1.05 billion in 2024 to $1.2 billion in 2025, representing a compound annual growth rate (CAGR) of 14.8%. The historic development can be linked to the rising incidence of cancer, heightened awareness about gene therapy, expanding patient base, improved healthcare access, and the increasing need for personalized medicine.

In coming years, the market size for viral vectors and plasmid DNA is predicted to experience significant expansion. The industry is projected to reach $1.66 billion in 2029, with an 8.4% compound annual growth rate (CAGR). The growth expected in this time frame is a result of factors such as budding therapeutic applications, reaction to the COVID-19 pandemic, increased financial backing, and global growth. Anticipated trends during the forecast period include advancements in viral vector and plasmid DNA production technology, gene editing improvements, customized vectors, enhancement in scalability and production, safety and quality measures, non-viral delivery methods, and global partnerships.

What Are the Key Drivers Behind the Growth of the Viral Vectors And Plasmid DNA Market?
An increase in cancer cases worldwide is fueling growth in the viral vector and plasmid DNA market. Factors contributing to the prevalence of most cancers include obesity, tobacco use, alcohol consumption, and unhealthy dietary habits. As predicted by the American Cancer Society in January 2022, the US is likely to see 1.9 million fresh cancer cases and about 1,670 cancer-related deaths daily, making up a total of 609,360 deaths for the year. Globally, the highest occurring cancers are lung, prostate, bowel, and breast cancer in women, which make up 43 percent of all new cancer diagnoses. Consequently, this upsurge in worldwide cancer cases is anticipated to escalate the demand in the viral vectors and plasmid DNA market in the forthcoming years.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3245&type=smp

Who Are the Major Industry Players Fueling Viral Vectors And Plasmid DNA Market Expansion?
Major companies operating in the viral vectors and plasmid dna market include FUJIFILM Diosynth Biotechnologies, FinVector Vision Therapies, Lonza Group AG, Cobra Biologics and Pharmaceutical Services, Brammer Bio, ??n?k? ??r??r?t??n, Cell and Gene Therapy Catapult, VGXI Inc., MassBiologics, Sanofi, Spark Therapeutics, UniQure NV, Thermo Fisher Scientific, VIROVEK, SIRION Biotech GmbH, ALDEVRON, Oxford BioMedica, PlasmidFactory GmbH & Co. KG, Biovian Oy, BioReliance Corporation, 4D Molecular Therapeutics, Renova Therapeutics, Shenzhen SiBiono GeneTech Co., Vigene Biosciences Inc., Novasep, Genzyme Corporation, Oxford Gene Technology, Richter-Helm, ??l?n NV, MolMed, Merck KGaA Inc., Catalent Inc., WuXi AppTec, GenScript Biotech Corporation, Eurogentec, Creative Biogene

Which Key Developments Are Influencing the Viral Vectors And Plasmid DNA Market?
The exorbitant prices of gene therapies present a significant hurdle in the viral vectors and plasmid DNA market. Gene therapies typically cost between $0.2 million and $2.1 million. For example, Gilead company's Yescarta is a gene therapy that comes with a price tag of approximately $0.3 million. In contrast, Bluebird Bio's Letiglobin, another gene therapy, costs roughly $2.1 million. Numerous factors contribute to these steep prices, such as government regulations, production expenditures, and more. Consequently, the prohibitive cost of gene therapies is curtailing the growth of the viral vector & plasmid DNA market.

How Is the Segmentation of the Viral Vectors And Plasmid DNA Market Defined?
The viral vectors and plasmid dna market covered in this report is segmented -

1) By Product: Plasmid DNA, Viral Vectors
2) By Disease: Infectious Diseases, Genetic Disorders, Cancer, Other Diseases
3) By Application: Gene And Cancer Therapies, Viral Infections, Immunotherapy, Formulation Development, Other Applications
4) By End User: Research Institutes, Biopharmaceutical And Pharmaceutical Companies

Subsegments:
1) By Plasmid DNA: Research-Grade Plasmid DNA, Clinical-Grade Plasmid DNA, GMP (Good Manufacturing Practice) Plasmid DNA
2) By Viral Vectors: Adenoviral Vectors, Lentiviral Vectors, AAV (Adeno-Associated Virus) Vectors, Retroviral Vectors, Vesicular Stomatitis Virus (VSV) Vectors

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/viral-vectors-and-plasmid-dna-global-market-report

What Is the Leading Region in the Viral Vectors And Plasmid DNA Market?
The countries covered in the viral vectors and plasmid DNA market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

What Is Covered In The Viral Vectors And Plasmid DNA Global Market Report?

- Market Size Analysis: Analyze the Viral Vectors And Plasmid DNA Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Viral Vectors And Plasmid DNA Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Viral Vectors And Plasmid DNA Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Viral Vectors And Plasmid DNA Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3245

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.